Research Article

Metabonomic Strategy to the Evaluation of Chinese Medicine Compound Danshen Dripping Pills Interfering Myocardial Ischemia in Rats

Table 4

Summary of intensity values of potential biomarkers in each group on day 3.

BiomarkersPeak intensity (mean ± sd, )
ControlCon. + CDDPShamModelMod. + CDDP

Glycine5.86 ± 0.6b,c5.51 ± 0.96b4.85 ± 0.94a4.41 ± 1.65a5.94 ± 1.8b,c
Urea190.9 ± 112.08b201.44 ± 108.76b201.59 ± 55.12b282.23 ± 72.75a,c211.97 ± 48.32b
L-alanine444.97 ± 64.71b432.48 ± 74.21b450.96 ± 56.85b586.25 ± 64.89a,c443.53 ± 98.11b
L-isoleucine260.88 ± 34.02b,c254.42 ± 39.69b211.84 ± 34.61a,b192.58 ± 33.25ac205.51 ± 54.06a
Cadaverine22.75 ± 11.3b23.12 ± 4.15b21.68 ± 11.31b45.53 ± 11.1a,c36.9 ± 14.92b
Succinic acid3.12 ± 2.16b3.13 ± 0.94b3.13 ± 1.63b2.40 ± 1.01a3.01 ± 2.07b
2-Butenedioic acid4.74 ± 1.61b4.61 ± 3.24b4.23 ± 3.98b1.24 ± 3.92a,c3.37 ± 3.98a,b
L-threonine209.33 ± 25.38b,c208.3 ± 27.54b181.25 ± 22.81a,b164.77 ± 35.78a,c189.33 ± 44.05b
Aminomalonic acid46.73 ± 29.21b46.21 ± 18.02b43.69 ± 44.56b36.41 ± 28.42a,c39.85 ± 25.14a
L-aspartic acid100.32 ± 11.51b97.98 ± 13.89b102.57 ± 7b112.83 ± 13.89a,c104.12 ± 21.12b
L-proline280.57 ± 22.74b,c289.33 ± 56.22b218.72 ± 31.35a,b95.1 ± 15.54a,c248.84 ± 64.37b
Creatinine6.39 ± 1.59b,c6.27 ± 3.44b7.25 ± 3.23a,b8.7 ± 3.73ac7.71 ± 3.24a,b
L-phenylalanine110.09 ± 10.46b,c106.57 ± 14.11b126.76 ± 8.24a,b177.46 ± 12.68a,c148.95 ± 24.79a,b
Citric acid6.95 ± 5.52b6.83 ± 4.4b6.33 ± 4.45b5.75 ± 2.64a,c6.06 ± 3.71a,b
D-xylose7.01 ± 1.96b,c7.08 ± 1.06b8.13 ± 1.07a,b9.76 ± 1.77a,c8.07 ± 1.15b
D-glucose2912.13 ± 190.45b2993.74 ± 210.95b3239.06 ± 255.96b5506.4 ± 255.01a,c3012.34 ± 209.33b
Lactic acid210.17 ± 15.22b211.91 ± 22.87b238.35 ± 16.13b381.36 ± 24.33a,c258.68 ± 16.45b
L-tyrosine44.57 ± 5.36b,c43.47 ± 7.74b56.62 ± 5.38a,b67.94 ± 9.93a,c62.72 ± 9.05a
Propanoic acid21.98 ± 6.65b,c22.5 ± 10.64b11.98 ± 6.28a10.89 ± 9.27a14.96 ± 10.47a,b
L-tryptophan421.7 ± 67.69b417.94 ± 69.49b434.8 ± 82.32b478.28 ± 118.65a,c451.78 ± 101.75a,b

Compared with the control group, a ; compared with the model group, b ; compared with the sham group, c .